Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Autism
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sun, Z.
Right arrow Articles by Cade, J. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sun, Z.
Right arrow Articles by Cade, J. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A Peptide Found in Schizophrenia and Autism Causes Behavioral Changes in Rats

Zhongjie Sun

University of Florida, USA

J. Robert Cade

University of Florida, USA

In a previous study we showed that ß-casomorphin-7 (ß-CM7) is taken up by brain regions relevant to schizophrenia and autism. The present experiment was designed to find whether ß-CM7 has any behavioral or analgesic effects in rats. About 65 seconds after treatment with different doses of ß-CM7, rats became restless and ran violently, with teeth chattering and with rapid respiration. Seven minutes later, the rats became inactive with less walking, distancing themselves from the other rat in the same cage, and sitting in, or putting their head against, the corner of the cage. The sound response was reduced and social interaction was absent. One hour later, the rats showed hyperdefensiveness. The above behavioral effects of ß-CM7 did not occur when rats were pretreated with naloxone (2 mg/kg, IP). The rats receiving saline did not show any behavioral changes throughout the 2 hour period of observation. ß-CM7 also demonstrated analgesic effects, which could be blocked by naloxone. The results suggest that ß-CM7 may play a role in behavioral disorders such as autism and schizophrenia.

Key Words: analgesia • autism • behavior • casomorphin • naloxone • schizophrenia

Autism, Vol. 3, No. 1, 85-95 (1999)
DOI: 10.1177/1362361399003001007


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Nutr Clin PractHome page
J. H. Elder
The Gluten-Free, Casein-Free Diet in Autism: An Overview With Clinical Implications
Nutr Clin Pract, December 1, 2008; 23(6): 583 - 588.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. F. White
Intestinal Pathophysiology in Autism
Experimental Biology and Medicine, June 1, 2003; 228(6): 639 - 649.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
B Thjodleifsson, K Davidsdottir, U Agnarsson, G Sigthorsson, M Kjeld, and I Bjarnason
Effect of Pentavac and measles-mumps-rubella (MMR) vaccination on the intestine
Gut, December 1, 2002; 51(6): 816 - 817.
[Abstract] [Full Text] [PDF]


Home page
Clin Child Psychol PsychiatryHome page
A. J. Wakefield
Commentary on 'The New Autism': One Family's Perspective
Clinical Child Psychology and Psychiatry, October 1, 2002; 7(4): 518 - 524.
[PDF]